Stromal expression of invasion-promoting, matrix-degrading proteases MMP-1 and -9 and the Ets 1 transcription factor in HNPCC carcinomas and sporadic colorectal cancers

International Journal of Cancer

Volumn 107, Issue 2, 2003, Pages 183-188

  Behrens, Peter ^a   Mathiak, Micaela ^a   Mangold, Elisabeth ^a   Kirdorf, Simona ^a   Wellmann, Axel ^a   Fogt, Franz ^b   Rothe, Marcus ^a   Florin, Alexandra ^a   Wernert, Nicolas ^a  

^a UNIVERSITY OF BONN   (Germany)

^b PENN PRESBYTERIAN MEDICAL CENTER   (United States)

Author keywords

Colon carcinoma; Hereditary nonpolyposis colorectal cancer; Metalloproteinases; Tumor stroma

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; TRANSCRIPTION FACTOR ETS 1;

ADENOMA; ARTICLE; CANCER INVASION; COLORECTAL CANCER; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; TUMOR DIFFERENTIATION; UPREGULATION;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CELL DIFFERENTIATION; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RNA, MESSENGER; STROMAL CELLS; TRANSCRIPTION FACTORS;

EID: 0141523120     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11336     Document Type: Article

References (44)

1. Lynch HT, Watson P, Shaw TG, Lynch JF, Harty AE, Franklin BA, Kapler CR, Tinley ST, Liu B, Lerman C. Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer: II, hereditary nonpolyposis colorectal carcinoma as a model. Cancer 1999;86:2457-63.
2. Lynch H. Hereditary nonpolyposis colorectal cancer (HNPCC). Cytogenet Cell Genet 1999;86:130-5.
3. Lynch H, de la Chapelle A. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet, 36:801-18.
4. Aaltonen LA, Peltomaki P. Genes involved in hereditary nonpolyposis colorectal carcinoma. Anticancer Res 1994;14:1657-60.
5. Bocker T, Schlegel J, Kullmann F, Stumm G, Zirngibl H, Epplen JT, Ruschoff J. Genomic instability in colorectal carcinomas: comparison of different evaluation methods and their biological significance. J Pathol 1996;179:15-9.
6. Genuardi M, Anti M, Capozzi E, Leonardi F, Fornasarig M, Novella E, Bellacosa A, Valenti A, Gasbarrini GB, Roncucci L, Benatti P, Percesepe A, Ponz R, de Leon M, Coco C, de Paoli A, Valentini M, Boiocchi M, Neri G, Viel A. MLH1 and MSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer. Int J Cancer 1998;75:835-9.
7. Percesepe A, Benatti P, Roncucci L, Sassatelli R, Fante R, Ganazzi D, Bellacosa A, Genuardi M, Neri G, Viel A, Ponz de Leon M. Survival analysis in families affected by hereditary non-polyposis colorectal cancer. Int J Cancer 1997;71:373-6.
8. Watson P, Lin KM, Rodriguez-Bigas MA, Smyrk T, Lemon S, Shashidharan M, Franklin B, Karr B, Thorson A, LynchHT. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer 1998;83:259-66.
9. Presciuttini S, Andreola S, Rodriguez-Bigas MA, Pizzetti P, Spinelli P. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer. Int J Cancer 1999;80:183-7.
10. Pyce C, Ralfkiaer E, Tryggvason K, Dano K. Messanger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 1993;142:359-65.
11. Murray G, Duncan M, O'Neil P, Melvin WT, Fothergill JE. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996;2:461-2.
12. Schmitt M, Janicke F, Moniwa N, Chucholowski N, Pache L, Graeff H. Tumor-associated urokinase-type plasminogen activator: biological and clinical significance. Biol Chem Hoppe Seyler 1992;373:611-22.
13. Goldberg G, Frisch S, He C, Wilhelm S, Reich R, Collier I. Secreted proteases. Regulation of their activity and their possible role in metastasis. Ann NY Acad Sci 1990;580:375-84.
14. Rabbani S, Xing R. Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies. Int J Oncol 1998;12:911-20.
15. Iwasaka C, Tanaka K, Abe M, Sato Y. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cellular Physiol 1996;169:522-31.
16. Watabe T, Yoshida K, Shindoh M, Kaya M, Fujikawa K, Sato H, Ishii S, Fujinaga K. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int J Cancer 1998;77:128-37.
17. Wasylyk C, Gutman A, Nicholson R, Wasylyk B. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J 1991;10:1127-34.
18. Grevin D, Chen JH, Raes M, Stéhelin D, Vandenbunder B, Desbiens X. Involvement of the proto-oncogene c-ets 1 and the urocinase plasminogen activator during mouse implantation and placentation. Int J Dev Biol 1993;37:519-29.
19. Wernert N, Gilles F, Fafeur V, Bouali F, Raes MB, Pyke C, Dupressoir T, Seitz G, Vandenbunder B, Stehelin D. Stromal expression of c-Ets 1 transcription factor correlates with tumor invasion. Cancer Res 1994;54:5683-8.
20. Wernert N, Raes M, Lassalle P, Dehouck MP, Gosselin B, Vandenbunder B, Stehelin D. C-ets 1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol 1992;140:119-27.
21. Vandenbunder B, Pardanaud L, Jaffredo T, Mirabel MA, Stehelin D. Complementary patterns of expression of c-ets 1, c-myb and c-myc in the blood-forming system of the chick embryo. Development 1989;107:265-74.
22. Lamberti C, Kruse R, Ruelfs C, Caspari R, Wang Y, Jungck M, Mathiak M, Malayeri RHR, Friedl W, Sauerbruch T, Propping P. Microsatellite instability: a useful diagnostic tool to select patients at high risk for hereditary non-polyposis colorectal cancer: a study in different groups of patients with colorectal cancer. Gut 1999;44:839-43.
23. Bertario L, Russo A, Sala P, Eboli M, Radice P, Presciuttini S, Andreola S, Rodriguez-Bigas MA, Pizzetti P, Spinelli P. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer. Int J Cancer 1999;80:183-7.
24. Levin B. Why hereditary nonpolyposis colorectal carcinoma patients appear to have better survival than patients with sporadic colorectal carcinoma. Cancer 1998;83:201-3.
25. Tomoda H, Baba H, Akazawa K. Prolonged survival in hereditary nonpolyposis colorectal cancer. Oncol Rep 1999;6:321-4.
26. Lynch H, Smyrk T. Colorectal cancer, survival advantage, and hereditary nonpolyposis colorectal carcinoma. Gastroenterology 1996;110:943-54.
27. Sankila R, Aaltonen L, Jarvinen H, Mecklin JP. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 1996;110:682-7.
28. Dolcetti R, Viel A, Doglioni C, Russo A, Guidoboni M, Capozzi E, Vecchiato N, Macri E, Fornasarig M, Boiocchi M. High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability. Am J Pathol 1999;154:1805-13.
29. Wernert N. The multiple roles of tumour stroma. Virchows Arch 1997;430:433-43.
30. Carmeliet P, Jain R. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57.
31. Otani Y, Okazaki I, Arai M, Kameyama K, Wada N, Maruyama K, Yoshino K, Kitajima M, Hosoda Y, Tsuchiya M. Gene expression of interstitial collagenase (matrix metalloproteinase 1) in gastrointestinal tract cancers. J Gastroenterol 1994;29:391-7.
32. Gray S, Yun K, Motoori T, Kuys YM. Interstitial collagenase gene expression in colonic neoplasia. Am J Pathol 1993;143:663-71.
33. Gallegos N, Smales C, Savage F, Hembry RM, Boulos PB. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer. Surg Oncol 1995;4:21-9.
34. Okada A, Bellocq J, Rouyer N, Chenard MP, Rio MC, Chambon P, Basset P. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 1995;92:2730-4.
35. Newell K, Witty J, Rodgers W, Matrisian LM. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis. Mol Carcinog 1994;10:199-206.
36. Valter M, Hügel A, Wiestler O, Pietsch T, Wernert N. Expression of Ets-1 transcription factor is related to neoangiogenesis and VEGF/VEGFR-1 expression in human gliomas. Cancer Res 1999;59:5608-14.
37. Wernert N, Stanjek A, Kiriakidis S, Hügel A, Jha HC, Mazitscheck R, Giannis A. Inhibition of in vivo angiogenesis by ets-1 antisense oligonucleotides: inhibition of Ets-1 transcription factor expression by the antibiotic fumagillin. Appl Chem 1999;111:3432-5.
38. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
39. Sunami E, Tsuno N, Osada T, Saito S, Kitayama J, Tomozawa S, Tsuruo T, Shibata Y, Muto T, Nagawa H. MMP-1 is a prognostic marker for hematogenous metastasis of colorectal cancer. Oncologist 2000;5:108-14.
40. Liabakk N, Talbot I, Smith R, Wilkinson K, Balkwill F. Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase 9 (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 1996;56:190-6.
41. Behrens P, Rothe M, Wellmann A, Krischler J, Wernert N. Rhe Ets-1 transcription factor is up-regulated together with MMP 1 and MMP 9 in the stroma of pre-invasive breast cancer. J Pathol 2001;194:43-50.
42. Naito S, Shimizu S, Matsuu M, Nakashima T, Yamashita S, Sekine I. Ets-1 upregulates matrix metalloproteinase-1 expression through extracellular matrix adhesion in vascular endothelial cells. Biochem Biophys Res Commun 2002;291:130-8.
43. Baker EA, Bergin FG, Leaper DJ. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Br J Surg 2000;87:1215-21.
44. Brand K, Baker AH, Perez-Canto A, Possling A, Sacharjat M, Geheeb M, Arnold W. Treatment of colorectal liver metastasis by adenoviral transfer of tissue inhibitor of metalloproteinases-2 into the liver tissue. Cancer Res 2000;60:5723-30.